Cheelcare Inc. (TSXV:CHER)

Cheelcare Statistics

Total Valuation

Cheelcare has a market cap or net worth of CAD 31.82 million. The enterprise value is 32.44 million.

Market Cap	31.82M
Enterprise Value	32.44M

Important Dates

The next estimated earnings date is Wednesday, April 15, 2026.

Earnings Date	Apr 15, 2026
Ex-Dividend Date	n/a

Share Statistics

Cheelcare has 19.76 million shares outstanding. The number of shares has increased by 38.71% in one year.

Current Share Class	19.76M
Shares Outstanding	19.76M
Shares Change (YoY)	+38.71%
Shares Change (QoQ)	+40.78%
Owned by Insiders (%)	15.53%
Owned by Institutions (%)	n/a
Float	16.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.49
PB Ratio	99.14
P/TBV Ratio	105.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.45
EV / Sales	19.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.99

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 2.20.

Current Ratio	1.24
Quick Ratio	0.33
Debt / Equity	2.20
Debt / EBITDA	n/a
Debt / FCF	-0.20
Interest Coverage	-4.76

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-38.05%
Return on Invested Capital (ROIC)	-746.08%
Return on Capital Employed (ROCE)	-460.08%
Weighted Average Cost of Capital (WACC)	5.31%
Revenue Per Employee	96,043
Profits Per Employee	-202,019
Employee Count	17
Asset Turnover	0.53
Inventory Turnover	1.08

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +463.33% in the last 52 weeks. The beta is 0.04, so Cheelcare's price volatility has been lower than the market average.

Beta (5Y)	0.04
52-Week Price Change	+463.33%
50-Day Moving Average	1.68
200-Day Moving Average	n/a
Relative Strength Index (RSI)	49.20
Average Volume (20 Days)	19,437

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cheelcare had revenue of CAD 1.63 million and -3.43 million in losses. Loss per share was -0.37.

Revenue	1.63M
Gross Profit	804,372
Operating Income	-1.87M
Pretax Income	-3.43M
Net Income	-3.43M
EBITDA	-1.73M
EBIT	-1.87M
Loss Per Share	-0.37

Balance Sheet

The company has 83,642 in cash and 705,464 in debt, with a net cash position of -621,822 or -0.03 per share.

Cash & Cash Equivalents	83,642
Total Debt	705,464
Net Cash	-621,822
Net Cash Per Share	-0.03
Equity (Book Value)	320,950
Book Value Per Share	0.02
Working Capital	355,047

Cash Flow

In the last 12 months, operating cash flow was -3.53 million and capital expenditures -73,069, giving a free cash flow of -3.61 million.

Operating Cash Flow	-3.53M
Capital Expenditures	-73,069
Depreciation & Amortization	145,534
Net Borrowing	181,741
Free Cash Flow	-3.61M
FCF Per Share	-0.18

Margins

Gross margin is 49.27%, with operating and profit margins of -114.81% and -210.34%.

Gross Margin	49.27%
Operating Margin	-114.81%
Pretax Margin	-210.34%
Profit Margin	-210.34%
EBITDA Margin	-105.90%
EBIT Margin	-114.81%
FCF Margin	n/a

Dividends & Yields

Cheelcare does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.71%
Shareholder Yield	-38.71%
Earnings Yield	-10.79%
FCF Yield	-11.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 16, 2025. It was a reverse split with a ratio of 0.3333333.

Last Split Date	Jul 16, 2025
Split Type	Reverse
Split Ratio	0.3333333

Scores

Cheelcare has an Altman Z-Score of 0.33 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.33
Piotroski F-Score	2